Abstract: Pressable glass-ceramic compositions for dental purposes of the composition I, II or III I II III (percent by weight) (percent by weight) (percent by weight) ZrO2 17-70%? ZrO2/Al2O3 15-70%? Al2O3 15-70%? SiO2 17-59%? SiO2 17-59%? SiO2 17-59%? Al2O3 ?2-15% ZrO2 ?2-15% ZrO2 ?2-15% Y2O3 ??0-6% Y2O3 ??0-6% Y2O3 ??0-6% K2O 3-12.5%? K2O 3-12.5%? K2O 3-12.5%? Na2O 0.2-8.5%?? Na2O 0.2-8.5%?? Na2O 0.2-8.5%?? Li2O 0-1.5% Li2O 0-1.5% Li2O 0-1.5% CaO 0.3-2% CaO 0.3-2% CaO 0.3-2% B2O3 0.1-5% B2O3 0.1-5% B2O3 0.1-5% F 0-2.5% F 0-2.5% F 0-2.5% CeO2 0.2-2% CeO2 0.2-2% CeO2 0.2-2% TiO2 0-1.5% TiO2 0-1.5% TiO2 0-1.5% are particularly suitable for the manufacturing of ceramic veneer frames.

Abstract: An antibiotic coating of implants is described, which is characterized in that the coating comprises at least one saturated, organic, hydrophobic, low molecular matrix former whose melting point is in the temperature range of 45° C. to 100° C., in which a low molecular, hydrophobic additive is dissolved and that an antibiotic/antibiotics is/are suspended in the mixture of matrix former and additive and/or in which an antibiotic/antibiotics miscible with a mixture of matrix former and additive is/are dissolved.

Abstract: A process by means of which the colonization by plaque on dental materials can be permanently prevented or delayed without the product properties of the dental material being negatively influenced. The process involves equipping the dental material with anti-plaque substance, namely at least one molecularly dispersely distributed octenidine salt or dequalinium salt. Also disclosed is a dental material so equipped.

Abstract: The invention relates to a PMMA revision bone cement having powder and liquid component, in which the powder component contains two or more granular antibiotics whose grain size distribution is equal in that the main screening fraction each of the individual antibiotics is in the same grain size range, in particular in the range of 100-250 ?m or 150-250 ?m.

Abstract: A surgical suture material with an antimicrobial surface is described, the surface exhibiting a coating containing a) at least one fatty acid, b) octenidine dichloride and/or dequalinium chloride and c) optionally oligomeric lactic acid esters. In addition, a process for coating surgical suture material is described which is characterized by the fact that the thread material is wetted with a homogeneous methanolic solution of octenidine dichloride and/or dequalinium chloride and subsequently the methanol is evaporated, a coating forming on the thread surface.

Abstract: A dental mixing device (10) is provided for generating a multi-component material (11) by squeezing out and mixing the components of the multi-component material (11) from at least one first (20, 20?) and one second cartridge (30, 30?). The first cartridge (20, 20?) and the second cartridge (30, 30?) are arranged in the dental mixing device (10) such as to be replaceable. The mixing device has a first (21) and a second feed line (31) for guiding the components respectively from the first cartridge (20, 20?) and the second cartridge (30, 30?) into a mixer (40) and has a motorized advancer (50) for squeezing the components from the first (20, 20?) and the second cartridge (30, 30?). At least the first cartridge (20, 20?) is a unit-dose package and has a first volume between 20 ml and 60 ml.

Abstract: Antibiotic/s containing bone substitute material is described which is characterized in that it is composed of a compacted mixture of granules of calcium sulfate dihydrate, calcium carbonate and at least one representative of the aminoglycoside antibiotics, lincosamide antibiotics, glycopeptide antibiotics, macrolide antibiotics, ketolide antibiotics, the nitroimidazoles, the fluorochinolone antibiotics and the oxazolidinone antibiotics, the steroid antibiotics, the antiseptic agents and the fungicidal/fungistatic antibiotics which are partly or entirely sheathed with a layer of glycerol tripalmitate and/or glycerol tristearate and/or glycerol trilaurate and/or 1-hexadecyl alcohol which connects the granules with each other.

Abstract: A local system for the release of active principle is described which consists of approximately spherical or rotation symmetrical bodies which are composed essentially of polymethyl methacrylate or polymethyl methacrylate co-methyl acrylate, zirconium dioxide or barium sulphate and one or more pharmaceutical active principles, in particular antibiotics, and which are produced by radical polymerisation, radical polymerisation activators effective in the temperature range of 10-80° C. or residues of these polymerisation activators from the groups of aromatic amines, heavy metal salts and barbiturates not being contained therein.

Abstract: A surgical suture material with an antimicrobial surface is described, the surface exhibiting a coating containing a) at least one fatty acid, b) octenidine dichloride and/or dequalinium chloride and c) optionally oligomeric lactic acid esters. In addition, a process for coating surgical suture material is described which is characterized by the fact that the thread material is wetted with a homogeneous methanolic solution of octenidine dichloride and/or dequalinium chloride and subsequently the methanol is evaporated, a coating forming on the thread surface.

Abstract: Form bodies, which can be rotationally-symmetrical or irregularly-shaped, consist of at least one member of the group of the antibiotic salts, gentamicin myristate, gentamicin palmitate, gentamicin stearate, tobramycin myristate, tobramycin palmitate, tobramycin stearate, amikacin myristate, amikacin palmitate, amikacin stearate, vancomycin palmitate, vancomycin stearate, ramoplanin palmitate, ramoplanin stearate, levofloxacin palmitate, levofloxacin stearate, ofloxacin palmitate, ofloxacin stearate, moxifloxacin palmitate, moxifloxacin stearate, clindamycin palmitate, and clindamycin stearate. A medical device for implantation, in which the form bodies are arranged on a biodegradable filament at a distance of 1 mm to 25 mm as well as a method for the manufacture of the medical device and the use of the form bodies or the medical device to treat chronic osteomyelitis are described.

Abstract: Containers that are soluble in liquid methylmethacrylate and contain the PMMA powder fraction of a two-component system made up of PMMA powder component and liquid MMA monomer component are useful as components of packaging of powder/liquid two-component material, such as dental material, investment material for histology or metallography or in veterinary medicine.

Abstract: A surgical suture material with an antimicrobial surface is described, the surface exhibiting a coating containing a) at least one fatty acid, b) octenidine dichloride and/or dequalinium chloride and c) optionally oligomeric lactic acid esters. In addition, a process for coating surgical suture material is described which is characterized by the fact that the thread material is wetted with a homogeneous methanolic solution of octenidine dichloride and/or dequalinium chloride and subsequently the methanol is evaporated, a coating forming on the thread surface.

Abstract: The invention relates to the use of erythropoietin (EPO), in particular EPO in a polymer-based pharmaceutical preparation which stabilises the active compound, for the treatment of traumatised skin, in particular for wound healing in the case of mechanical or pathological injuries or in the case of burns. In particular, the invention also relates to specific viscous or gelatinous formulations, in particular based on polysaccharides, preferably cellulose derivatives, which comprise EPO and are capable of stabilising the latter and releasing it slowly and uniformly to the wound.

Abstract: The invention relates to a plastic capsule for the storage and delivery of dental material, the capsule exhibiting a cylindrical cavity in a first capsule section and connecting the first and a third capsule section in a second capsule section and the third capsule section being a dispensing nipple angled with respect to the first capsule section characterised in that the first capsule section exhibits a reinforced longitudinal side and a longitudinal formed in a round manner and the reinforced longitudinal side is an edge on a round tube, the edge forming the reinforcement, and to similar capsules with two reinforcement edges.

Abstract: An arrangements optimised for the mixing control of several components to be mixed by the user. The components include a paste A to be dispensed in a strand and another component B. A includes A1 which is white or a lightly coloured base paste and A2 is an intensely coloured colour paste. The components are within a container with a discharge aperture. Given stripes of A1 in A2 or of A2 in A1 are being arranged or A1 and A2 are stored separately and, at the discharge aperture, a device for producing stripes of A1 in A2 or of A2 in A1 is provided such that A1 and A2 together result in a stripe pattern in the discharged strand which is provided for mixing with at least one further component B.

Abstract: The invention relates to a measuring device of flexible material for the determination of parameters for the production of dental prostheses which combines different functions, including protractor, spacing template, ruler and an option of utilizing a compass-formed modulus shear measuring module to facilitate shearing.

Abstract: The present invention relates to a process for the sterilization and/or germ reduction of impression material by means of radiation.

Abstract: Dental composite materials based on (meth)acrylate, exhibiting a proportion of TCD monomers in the total composition of 1-15% by weight and the quotient of flexural strength/shrinkage tension is at least 35.

Abstract: Dental composites comprising monomers, crosslinking agents, fillers, and initiators, in which the crosslinking agent comprises more than 50% by weight of the acrylate monomer TCD-DI-HEA, and the cyctotoxicity of the cured composite as determined according to the standard requirements of ISO 10993-5 and DIN EN ISO 7405 is assessed into the category “no cytotoxic potential”.

Abstract: The present invention relates to impression compounds based on polyether derivatives, a process for their production and their use.